Bay Area Reporter - May 18, 2006
Bob Roehr
The ice cracked on May 9 when staff members from the House and Senate, who have been working on crafting a bipartisan, bicameral piece of legislation, released a timeline for action, and the following day, a draft of the bill itself. Comments were due by the close of business May 12.
The final Senate version of the legislation was scheduled for release on May 16, with committee markup on May 17, and a vote in the full Senate likely within weeks. The House version is likely to be dealt with in committee in time for floor action during "Health Week," which begins June 19.
The proposed Senate markup date could be delayed, according to Ernest Hopkins, director of federal affairs for the San Francisco AIDS Foundation. Hopkins told the Bay Area Reporter Monday, May 15 that he and other state advocates have been working hard to reduce the projected loss of CARE Act funding.
"Overall, I'd say it's a mixed bag," Hopkins said of the draft legislation.
The congressional tactics were devised by staff to minimize opportunities for amendments so that both chambers pass the same piece of legislation and avoid the need for a conference to iron out differences, observers said.
The reauthorized CARE Act is a tightly crafted set of compromises where none of the competing advocacy interests gets all that they wanted or loses all that they feared. Nor does it appear likely that significant new funding will be added to meet the growing needs, though incremental increases in money may reduce the pain somewhat.
The draft retains the basic structure of the program titles; however, it does further subdivide Title I into three categories of cities receiving support. It establishes a process for the transition to distributing funds based on reported cases of HIV rather than AIDS. And it increases funding in areas where the epidemic has recently grown most rapidly, in the smaller cities and rural areas of the South. This often is at the expense of the cities where the epidemic first appeared.
'Core services'
One controversial new requirement is that 75 percent of funds go to "core services," but that term has not been defined in the legislation. Some AIDS advocates are pressing for Congress to develop a definition rather than leave it up to the regulatory prerogative of the secretary of Health and Human Services.
AIDS Action, the lobbying arm for most of the nation's community-based AIDS services organizations, said in its written comments that it was "unable to take a specific position on the draft bill" until funding information is released.
Data runs on the financial impact of the changes for each program title to each state were not released until after the comment period had closed on Friday.
AIDS Action is particularly concerned that the 75 percent of funding for core services be calculated only after the 10 percent administrative overhead and 5 percent grant management allocations are deducted. It also argued that the definition of core services should include case management and substance abuse treatment for people living with HIV.
The draft legislation also foresees development and switching to a "severity of need index" as the basis for allocating funds. But this crucial mechanism also has not been defined in the bill.
SFAF's Hopkins said that of significance to California and San Francisco is the proposed move away from the present method of counting AIDS cases, which he maintained resulted in an undercount, and switching to an actual case count. That will result in the city and state recouping some of the money expected to be lost with the change to the "hold harmless" provision for San Francisco.
"We won't get the whole percentage back," Hopkins said, "but we'll get to a level of funding in San Francisco and California that is reflective of the case count."
Regarding the hold harmless provision, Hopkins said SFAF has come to the realization that the provision will not be maintained through the entire reauthorization. However, he said negotiations are continuing to have the hold harmless provision remain in effect for four years of the reauthorization, rather than three.
The change in case count, and having the hold harmless provision remain in effect for four years would mean that the projected funding cuts for San Francisco would not be "as dramatic as it would have been," Hopkins said.
"Hold harmless protects about $7 million in San Francisco," he noted.
The National Association of State and Territorial AIDS Directors noted that government panels "are having great difficulty identifying reliable universally available data that might be used to make allocation decisions. At a time when the panels are forced to use a proxy for even the most straightforward indicator of need (i.e., HIV cases), we believe it premature to direct the allocation of funds to states based on a yet to be tested severity-of-need index."
AIDS Action criticized the prohibition of funding, programs, and materials relating to sexual activity and injection drug use.
"HIV is a disease about sex and drugs. It cannot be prevented or adequately treated without addressing the issues of sex and drugs," the agency said in a statement.
AIDS Action also criticized the short time period for comments, which "may not allow the community proper consideration of a number of important issues." Others echoed that concern.
Reactions
NASTAD is "extremely disappointed" with the draft bill and said so in a seven-page letter to the sponsoring congressmen.
"The current proposal would make a complicated piece of legislation even more so and would further fragment a system of care designed to ensure a comprehensive system of care and treatment for people living with HIV/AIDS across the U.S. ... [It] would significantly weaken the role of the states while increasing their administrative burden,? the organization said in its letter.
Bill Arnold, who represents the Title II Community AIDS National Network, was a bit less harsh. "This legislation may maintain and even slightly improve the status quo but it will not and cannot be expected to provide the current standard of care to patients in treatment nor provide the resources necessary to bring those who should be treated into care," he wrote Hill staffers in response to the draft legislation.
The Title II network focuses on the AIDS Drug Assistance Program.
Arnold criticized the federal government for being either "unwilling or unable to provide any needs-based estimates" of what levels of funding the program should be providing. He urged increasing the eligibility criteria from 200 percent to 300 percent of the federal poverty level, and technical changes to the hold harmless provision that would limit the reduction in ADAP funding to a single state to no more than 7.5 percent over five years.
AIDS advocates have pushed for an addition of $70 million each year for ADAP to fully fund recommended drug formularies and eliminate the waiting lists that restrict access to drugs. The draft bill calls for a onetime addition of only $30 million.
A technical fix is being offered by members of the Senate Finance Committee that would allow costs incurred through ADAP, the Indian Health Service, and certain other qualified programs and designated hospitals to count toward a beneficiary's annual out of pocket threshold for purposes of Medicare.
"This is likely to provide $35 to $50 million a year in relief to ADAPs," said Arnold. "It is vital to ensuring that ADAP is the payer of last resort," and make most effective use of those funds.
***
Cynthia Laird contributed to this article.
060518
BR060511
Copyright © 2006 - The Bay Area Reporter. Reproduction of this article (other than one copy for personal reference) must be cleared through the The Bay Area Reporter.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .